Australia’s TGA Proposes Major Update of 2001 Labeling Regulations
This content is provided by RegLink News, publishers of e-weekly global regulatory news. RegLink offers a 30-day free trial and 15% discount on Global Update subscriptions to RAPS members.
Australia’s Therapeutic Goods Administration (TGA) is seeking comments on multiple proposals for the first major revision of its 2001 Drug Labeling Regulations.
The regulations are intended to address safety risks posed by issues such as:
- The difficulty of finding information about a medicine's active ingredient
- The use of a single brand name across a range of products (i.e. brand extensions)
- Medicine names that look alike and sound alike, which can lead to use of the incorrect medicine
- Medicine containers and packaging which appear similar to that of another medicine
- Lack of a standardized format for information included on medicines labels and packaging
- Dispensing stickers that cover up important information
TGA is calling for public comment on revisions contained in the following documents:
- Therapeutic Goods Order (TGO) No 79 - Standard for the labeling of medicines
- Comparing TGO 79 with TGO 69
- Consultation: Guideline for the labelling of medicines
The closing date for comments is 7 October 2014.